Tenax Therapeutics Provides Regulatory Update on Levosimendan
Go back to Tenax Therapeutics Provides Regulatory Update on Levosimendan| (NASDAQ: TENX) | Delayed: 1.97 -0.16 (7.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.13 | 52 Week High | $3.40 | |||
| Open | $2.13 | 52 Week Low | $1.34 | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $1.95 | EPS | $0.00 | |||
| Volume | 3,740,756 | |||||

